• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在美国成年人群体中,使用经典迷幻剂与心理困扰和自杀倾向的减轻有关。

Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population.

作者信息

Hendricks Peter S, Thorne Christopher B, Clark C Brendan, Coombs David W, Johnson Matthew W

机构信息

Department of Health Behavior, University of Alabama at Birmingham, Birmingham, AL, USA

Department of Health Behavior, University of Alabama at Birmingham, Birmingham, AL, USA.

出版信息

J Psychopharmacol. 2015 Mar;29(3):280-8. doi: 10.1177/0269881114565653. Epub 2015 Jan 13.

DOI:10.1177/0269881114565653
PMID:25586402
Abstract

Mental health problems are endemic across the globe, and suicide, a strong corollary of poor mental health, is a leading cause of death. Classic psychedelic use may occasion lasting improvements in mental health, but the effects of classic psychedelic use on suicidality are unknown. We evaluated the relationships of classic psychedelic use with psychological distress and suicidality among over 190,000 USA adult respondents pooled from the last five available years of the National Survey on Drug Use and Health (2008-2012) while controlling for a range of covariates. Lifetime classic psychedelic use was associated with a significantly reduced odds of past month psychological distress (weighted odds ratio (OR)=0.81 (0.72-0.91)), past year suicidal thinking (weighted OR=0.86 (0.78-0.94)), past year suicidal planning (weighted OR=0.71 (0.54-0.94)), and past year suicide attempt (weighted OR=0.64 (0.46-0.89)), whereas lifetime illicit use of other drugs was largely associated with an increased likelihood of these outcomes. These findings indicate that classic psychedelics may hold promise in the prevention of suicide, supporting the view that classic psychedelics' most highly restricted legal status should be reconsidered to facilitate scientific study, and suggesting that more extensive clinical research with classic psychedelics is warranted.

摘要

心理健康问题在全球范围内普遍存在,而自杀作为心理健康不佳的一个重要后果,是主要的死亡原因之一。使用经典迷幻剂可能会使心理健康状况得到持久改善,但经典迷幻剂的使用对自杀倾向的影响尚不清楚。我们在控制一系列协变量的同时,评估了在过去五年(2008 - 2012年)美国国家药物使用和健康调查中汇总的超过19万名成年受访者中,经典迷幻剂的使用与心理困扰和自杀倾向之间的关系。终生使用经典迷幻剂与过去一个月心理困扰的几率显著降低相关(加权优势比(OR)=0.81(0.72 - 0.91)),过去一年自杀念头(加权OR = 0.86(0.78 - 0.94)),过去一年自杀计划(加权OR = 0.71(0.54 - 0.94)),以及过去一年自杀未遂(加权OR = 0.64(0.46 - 0.89))相关,而终生非法使用其他药物在很大程度上与这些结果的可能性增加相关。这些发现表明,经典迷幻剂在预防自杀方面可能具有前景,支持应重新考虑经典迷幻剂最严格的法律地位以促进科学研究的观点,并表明有必要对经典迷幻剂进行更广泛的临床研究。

相似文献

1
Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population.在美国成年人群体中,使用经典迷幻剂与心理困扰和自杀倾向的减轻有关。
J Psychopharmacol. 2015 Mar;29(3):280-8. doi: 10.1177/0269881114565653. Epub 2015 Jan 13.
2
Prevalence and epidemiological associates of novel psychedelic use in the United States adult population.美国成年人群中新致幻剂使用的流行率和流行病学关联。
J Psychopharmacol. 2019 Sep;33(9):1058-1067. doi: 10.1177/0269881119827796. Epub 2019 Feb 28.
3
Psychedelics not linked to mental health problems or suicidal behavior: a population study.迷幻剂与心理健康问题或自杀行为无关:一项人群研究。
J Psychopharmacol. 2015 Mar;29(3):270-9. doi: 10.1177/0269881114568039. Epub 2015 Mar 5.
4
MDMA/ecstasy use and psilocybin use are associated with lowered odds of psychological distress and suicidal thoughts in a sample of US adults.在一项美国成年人样本中,使用 MDMA/摇头丸和使用裸盖菇素与降低心理困扰和自杀念头的几率有关。
J Psychopharmacol. 2022 Jan;36(1):46-56. doi: 10.1177/02698811211058923. Epub 2022 Jan 5.
5
The relationships of classic psychedelic use with criminal behavior in the United States adult population.经典迷幻药使用与美国成年人群体犯罪行为的关系。
J Psychopharmacol. 2018 Jan;32(1):37-48. doi: 10.1177/0269881117735685. Epub 2017 Oct 17.
6
Psychedelics and mental health: a population study.迷幻剂与心理健康:一项人群研究。
PLoS One. 2013 Aug 19;8(8):e63972. doi: 10.1371/journal.pone.0063972. eCollection 2013.
7
Population Survey Data Informing the Therapeutic Potential of Classic and Novel Phenethylamine, Tryptamine, and Lysergamide Psychedelics.人口调查数据揭示经典和新型苯乙胺、色胺及麦角酰胺类致幻剂的治疗潜力
Front Psychiatry. 2020 Feb 11;10:896. doi: 10.3389/fpsyt.2019.00896. eCollection 2019.
8
Suicidal thoughts and behaviors among adults aged ≥18 years--United States, 2008-2009.成年≥18 岁人群中的自杀想法和行为——美国,2008-2009 年。
MMWR Surveill Summ. 2011 Oct 21;60(13):1-22.
9
Associations between lifetime classic psychedelic use and markers of physical health.一生中经典致幻剂使用与身体健康标志物之间的关联。
J Psychopharmacol. 2021 Apr;35(4):447-452. doi: 10.1177/0269881121996863. Epub 2021 Mar 9.
10
The association of psychedelic use and opioid use disorders among illicit users in the United States.美国非法使用者中迷幻剂使用与阿片类药物使用障碍之间的关联。
J Psychopharmacol. 2017 May;31(5):606-613. doi: 10.1177/0269881117691453. Epub 2017 Feb 14.

引用本文的文献

1
Perspectives on Trauma Treatment, Self-Management Strategies, and Attitudes Toward Psychedelic Therapies in Individuals with Psychological Trauma Symptoms.心理创伤症状个体对创伤治疗、自我管理策略以及迷幻疗法态度的观点
Psychiatry Clin Psychopharmacol. 2025 Jul 30;35(Suppl 1):S3-S19. doi: 10.5152/pcp.2025.24934.
2
Self-inflicted transorbital intracranial foreign body following ingestion of hallucinogenic psilocybin mushrooms.摄入致幻的裸盖菇素蘑菇后自伤性经眶颅内异物。
Am J Ophthalmol Case Rep. 2025 Jun 2;39:102359. doi: 10.1016/j.ajoc.2025.102359. eCollection 2025 Sep.
3
Naturalistic Psychedelic Use and Psychotic Symptoms: A Cross-Sectional Study of Individuals with a Personal or Family History of Psychotic or Bipolar Disorders.
自然主义的迷幻剂使用与精神病症状:一项针对有个人或家族精神病或双相情感障碍病史个体的横断面研究。
Psychedelic Med (New Rochelle). 2025 May 26;3(2):93-102. doi: 10.1089/psymed.2024.0036. eCollection 2025 Jun.
4
Race and Gender Differences in the Moderating Relationship of Psychedelics on Stigma and Distress.迷幻剂对污名和痛苦的调节关系中的种族和性别差异
Psychedelic Med (New Rochelle). 2025 May 26;3(2):71-80. doi: 10.1089/psymed.2024.0021. eCollection 2025 Jun.
5
The molecular mechanisms through which psilocybin prevents suicide: evidence from network pharmacology and molecular docking analyses.裸盖菇素预防自杀的分子机制:来自网络药理学和分子对接分析的证据。
Transl Psychiatry. 2025 Jun 16;15(1):202. doi: 10.1038/s41398-025-03410-7.
6
The Relationships Between Healthcare Access, Gender, and Psychedelics and Their Effects on Distress.医疗保健可及性、性别与迷幻剂之间的关系及其对痛苦的影响。
Healthcare (Basel). 2025 May 16;13(10):1158. doi: 10.3390/healthcare13101158.
7
A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.裸盖菇素试验中使用的研究材料的全领域综述与分析:二十年研究评估
Psychedelic Med (New Rochelle). 2025 Feb 27;3(1):1-18. doi: 10.1089/psymed.2024.0019. eCollection 2025 Mar.
8
Psychedelic Therapist Sexual Misconduct and Other Adverse Experiences Among a Sample of Naturalistic Psychedelic Users.自然主义迷幻药使用者样本中的迷幻疗法治疗师性行为不端及其他不良经历
Psychedelic Med (New Rochelle). 2025 Feb 27;3(1):41-47. doi: 10.1089/psymed.2024.0011. eCollection 2025 Mar.
9
Psychedelics and Suicide-Related Outcomes: A Systematic Review.致幻剂与自杀相关结局:一项系统评价
J Clin Med. 2025 Feb 20;14(5):1416. doi: 10.3390/jcm14051416.
10
American Psychiatrists' Opinions About Classic Hallucinogens and Their Potential Therapeutic Applications: A 7-Year Follow-Up Survey.美国精神病学家对经典致幻剂及其潜在治疗应用的看法:一项为期7年的随访调查。
Psychedelic Med (New Rochelle). 2024 Mar 12;2(1):1-9. doi: 10.1089/psymed.2023.0036. eCollection 2024 Mar.